Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000912057-02-015789
Filing Date
2002-04-19
Accepted
2002-04-19 00:00:00
Documents
11

Document Format Files

Seq Description Document Type Size
1 FORM S-3 a2076183zs-3.htm S-3 273388
3 EX-4.1 a2076183zex-4_1.txt EX-4.1 349818
4 EX-4.3 a2076183zex-4_3.txt EX-4.3 50056
5 EX-4.4 a2076183zex-4_4.txt EX-4.4 65754
6 EX-4.5 a2076183zex-4_5.txt EX-4.5 15744
7 OPINION OF SAUL EWING a2076183zex-5_1.txt EX-5.1 1918
8 EXHIBIT 12.1 a2076183zex-12_1.txt EX-12.1 2300
9 CONSENT OF KPMG a2076183zex-23_1.txt EX-23.1 883
10 CONSENT OF ERNST & YOUNG a2076183zex-23_2.txt EX-23.2 911
11 EXHIBIT 25.1 a2076183zex-25_1.txt EX-25.1 11439
12 G350050.JPG g350050.jpg GRAPHIC 9503
  Complete submission text file 0000912057-02-015789.txt   784426
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-3 | Act: 33 | File No.: 333-86624 | Film No.: 02615804
SIC: 2835 In Vitro & In Vivo Diagnostic Substances